Familial primary hiliary cirrhosis reassessed: A geographically-based population study

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 402-407

  Jones, David E J ^a,b   Watt, Fiona E ^a   Metcalf, Jane V ^a   Bassendine, Margaret F ^a   James, Oliver F W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Epidemiology; Familial; Immunogenetics; Liver cirrhosis, biliary

Indexed keywords

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; DISEASE PREDISPOSITION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PEDIGREE; RISK FACTOR;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PEDIGREE; RISK FACTORS;

EID: 0032587434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80097-X     Document Type: Article

References (24)

1. Kaplan M. Primary biliary cirrhosis. N Engl J Med. 335:1996;1570-1579.
2. Jones DEJ, Bassendine MF. Primary biliary cirrhosis. J Intern Med. 241:1997;127-130.
3. Metcalf JV, Bhopal RS, Gray J, Howel D, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle-upon-Tyne, England. Int J Epidemiol. 26:1997;830-836.
4. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol. 20:1994;698-701.
5. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
6. Gregory WL, Bassendine MF. Genetic factors in primary biliary cirrhosis. J Hepatol. 20:1994;689-692.
7. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 85:1996;311-318.
8. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med. 60:1967;1257-1261.
9. Myszor M, James OFW. The epidemiology of primary biliary cirrhosis in the north-east of England: an increasingly common disease? Q J Med. 75:1990;377-385.
10. Caldwell SH, Leung SC, Spivey JR, Prindiville T, de Medina M, Saicheur T, et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology. 16:1992;899-905.
11. James OFW, Bhopal R, Howell D, Gray J, Burt AD, Metcalf JV. Demography of primary biliary cirrhosis in North-East England. Gastroenterology. 1998;. in press.
12. Manns MP, Bremm A, Schneider PM, Notghi A, Gerken G, Prager-Eberle M, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology. 101:1991;1367-1373.
13. Gregory WL, Mehal WZ, Dunn AN, Cavanagh G, Idle JR, James OFW, et al. Primary biliary cirrhosis:contribution of HLA class II allele DR8. Q J Med. 86:1993;393-399.
14. Mehal WZ, Gregory WL, Lo YMD, Cross SJ, Fleming KA, Bassendine MF, et al. Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology. 20:1994;1213-1219.
15. Underhill JA, Donaldson PT, Bray GP, Doherty DG, Portmann BC, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology. 16:1992;1404-1408.
16. Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, et al. DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol. 21:1994;1053-1060.
17. Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (primary biliary cirrhosis). Tissue Antigens. 29:1987;141-145.
18. Gregory WL, Daly AK, Dunn AN, Cavanagh G, Idle JR, James OFW, et al. Analysis of HLA-class II encoded antigen processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q J Med. 87:1994;237-244.
19. Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, et al. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol. 28:1998;820-823.
20. Watt FE, Grove J, Daly AK, Gregory W, Day CP, James OFW, et al. TNF and HLA DR8 polymorphisms in PBC: genetic control of disease progression. [abstract] Hepatology. 26:1997;440A.
21. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA. 92:1995;8560-8565.
22. Wordsworth P. Genes and arthritis. Br Med Bull. 51:1995;249-266.
23. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 347:1996;1212-1217.
24. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet. 40:1987;1-14.